XML 67 R53.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Reporting - Schedule of CODM also Reviews DefenCath Sales Separately From Sales (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Product Sales:    
Total Revenues $ 127,427 $ 39,082
DefenCath    
Product Sales:    
Total Revenues 97,511 39,082
Melinta Portfolio    
Product Sales:    
Total Revenues 24,405 0
Product sales, net    
Product Sales:    
Total Revenues 121,916 39,082
Contract revenue    
Product Sales:    
Total Revenues $ 5,511 $ 0